Eagle Pharmaceuticals Price on December 31, 2023

EGRXDelisted Stock  USD 1.99  0.02  1.02%   
If you're considering investing in Eagle Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Eagle Pharmaceuticals stands at 1.99, as last reported on the 1st of December, with the highest price reaching 2.40 and the lowest price hitting 1.93 during the day. Eagle Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.33, which denotes the company had a -0.33% return per unit of risk over the last 3 months. Eagle Pharmaceuticals exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Eagle Pharmaceuticals' Standard Deviation of 6.74, mean deviation of 3.94, and Variance of 45.47 to check the risk estimate we provide.
  
Eagle Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.3303

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsEGRX

Estimated Market Risk

 9.03
  actual daily
80
80% of assets are less volatile

Expected Return

 -2.98
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.33
  actual daily
0
Most of other assets perform better
Based on monthly moving average Eagle Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Eagle Pharmaceuticals by adding Eagle Pharmaceuticals to a well-diversified portfolio.

Eagle Pharmaceuticals Valuation on December 31, 2023

It is possible to determine the worth of Eagle Pharmaceuticals on a given historical date. On December 31, 2023 Eagle was worth 5.48 at the beginning of the trading date compared to the closed value of 5.23. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Eagle Pharmaceuticals pink sheet. Still, in general, we apply an absolute valuation method to find Eagle Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Eagle Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Eagle Pharmaceuticals' related companies.
 Open High Low Close Volume
  5.24    5.48    5.21    5.42    133,903  
12/29/2023
  5.48    5.48    5.13    5.23    253,370  
  5.26    5.74    5.20    5.66    236,556  
Backtest Eagle Pharmaceuticals  |  Eagle Pharmaceuticals History  |  Eagle Pharmaceuticals Valuation   PreviousNext  
Open Value
5.48
5.23
Closing Value
32.57
Upside

Eagle Pharmaceuticals Trading Date Momentum on December 31, 2023

On January 02 2024 Eagle Pharmaceuticals was traded for  5.66  at the closing time. The top price for the day was 5.74  and the lowest listed price was  5.20 . The trading volume for the day was 236.6 K. The trading history from January 2, 2024 was a factor to the next trading day price jump. The overall trading delta against the next closing price was 8.22% . The overall trading delta against the current closing price is 3.63% .

Eagle Pharmaceuticals Fundamentals Correlations and Trends

By evaluating Eagle Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Eagle Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Eagle financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Eagle Pharmaceuticals Pink Sheet history

Eagle Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Eagle is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Eagle Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Eagle Pharmaceuticals stock prices may prove useful in developing a viable investing in Eagle Pharmaceuticals
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. Eagle Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Woodcliff Lake, New Jersey. Eagle Pharmaceuticals operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 102 people.

Eagle Pharmaceuticals Pink Sheet Technical Analysis

Eagle Pharmaceuticals technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
A focus of Eagle Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Eagle Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Eagle Pharmaceuticals Period Price Range

Low
December 1, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Eagle Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Eagle Pharmaceuticals December 1, 2024 Market Strength

Market strength indicators help investors to evaluate how Eagle Pharmaceuticals pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Eagle Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Eagle Pharmaceuticals pink sheet market strength indicators, traders can identify Eagle Pharmaceuticals entry and exit signals to maximize returns

Eagle Pharmaceuticals Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Eagle Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Eagle Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of Eagle to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Consideration for investing in Eagle Pink Sheet

If you are still planning to invest in Eagle Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Eagle Pharmaceuticals' history and understand the potential risks before investing.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Commodity Directory
Find actively traded commodities issued by global exchanges
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital